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V  N the Washington v. Glucksberij and Vacco v. 
I  Quill decisions rejecting a constitutional right 
I  to physician-assisted suicide, the Supreme Court 
^  allowed each state to decide whether to legalize 
the intervention.1 In state legislatures rather than 
courtrooms, factual claims about the probable extent 
and implications o f permitting physician-assisted sui­
cide assume a preeminent role in the debate about 
legalization.2 Particularly sensitive in these discus­
sions will be the issue o f the potential cost savings 
from legalizing physician-assisted suicide, and how 
the savings might influence decision making by 
health care institutions, physicians, families, and ter­
minally ill patients.3 6
Although we do not agree with each other about 
the ethics or optimal social policy regarding physi­
cian-assisted suicide and euthanasia, we do agree that 
the claims o f cost savings distort the debate. Within 
the limits o f available data, we offer an assessment of 
the potential cost savings from legalizing physician- 
assisted suicide, demonstrating that the savings can 
be predicted to be very small — less than 0 .1 percent 
o f both total health care spending in the United 
States and an individual managed-care plan’s budget.
S P E C U L A T IN G  A B O U T  C O S T  S A V IN G S  
F R O M  P H Y S IC IA N -A S S IS T E D  S U IC ID E
There is a widespread perception that the United 
States spends an excessive amount on high-technol- 
ogv health care for dying patients.720 Many com­
mentators note that 27 to 30 percent o f the Medi­
care budget is spent on the 5 percent o f Medicare 
patients who die each year.21 They also note that the 
expenditures increase exponentially as death approach­
es, so that the last month o f life accounts for 30 to 
40 percent o f the medical care expenditures in the 
last year o f life. To many, savings from reduced use
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o f expensive technological interventions at the end 
o f life are both necessary and desirable.11’12’18’19
Many have linked the effort to reduce the high cost 
o f death with the legalization o f physician-assisted 
suicide. O ne commentator observed: “Managed care 
and managed death [through physician-assisted sui­
cide] are less expensive than fee-for-service care and 
extended survival. Less expensive is better.” 22 Some 
o f the amicus curiae briefs submitted to the Supreme 
Court expressed the same logic: “Decreasing avail­
ability and increasing expense in health care and the 
uncertain impact o f managed care may intensify pres­
sure to choose physician-assisted suicide” 23 and “the 
cost effectiveness o f hastened death is as undeniable 
as gravity. The earlier a patient dies, the less costly 
is his or her care.” 24 Indeed, the Supreme Court 
noted the potential for cost-saving motives to influ­
ence the legalization and use o f physician-assisted 
suicide, speculating that “if physician-assisted suicide 
were permitted, many might resort to it to spare 
their families the substantial financial burden o f end- 
of-life health care costs.” 1
F A C T O R S  D E T E R M IN IN G  S A V IN G S  F R O M  
P H Y S IC IA N -A S S IS T E D  S U IC ID E
Computing the likely cost savings from legalizing 
physician-assisted suicide is based on three factors: 
( 1 ) the number o f patients who might commit sui­
cide with the assistance o f a physician if it is legal­
ized; (2 ) the proportion o f medical costs that might 
be saved by the use o f physician-assisted suicide, 
which is related to the amount o f time that a pa­
tient’s life might be shortened; and (3) the total cost 
o f medical care for patients who die.
Each o f these factors is uncertain. Although avail­
able data indicate that physicians in the United States 
currently provide euthanasia and assistance with sui­
cide to some patients,25’26 it is impossible to deter­
mine how many additional Americans would die as 
a result o f  physician-assisted suicide if it were legal­
ized. The savings from legalization would depend 
on the additional number o f  physician-assisted sui­
cides beyond the current number. Since predictions 
about any patient’s precise date o f death are inherently 
uncertain, it is impossible to determine how much 
life would be forgone. Finally, only limited data are 
available on the costs o f care near the end o f life in
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the United States.15'16'21 However, by combining data 
on physician-assisted suicide and euthanasia in the 
Netherlands, where these interventions are openly 
performed27’28 and have been studied,29'31 and avail­
able U.S. data on costs at the end o f life, we can es­
timate the cost savings that would be realized in the 
United States if physician-assisted suicide were legal­
ized. Although such an estimate is very crude, sen­
sitivity analysis can minimize the effect o f the un ­
certainty by providing the range o f savings under 
reasonable conditions.
T H E  N U M B E R  O F  P A T IE N T S  W H O  M IG H T  
C H O O S E  P H Y S IC IA N -A S S IS T E D  S U IC ID E
In the Netherlands, approximately 3100 cases o f 
euthanasia and 550 cases o f physician-assisted sui­
cide occur annually, representing 2.3 percent and 
0.4 percent, respectively, o f  all deaths.31 (There are 
an additional 1000 cases [0.7 percent] in which eu­
thanasia is performed without the patients’ explicit, 
current consent.31 Such cases are neither sanctioned 
in the Netherlands nor permitted by the current pro­
posals for legalization o f physician-assisted suicide in 
the United States.) About 80 percent o f  deaths by 
physician-assisted suicide or euthanasia in the N eth­
erlands involve patients with cancer, representing
6 percent o f  all deaths from cancer.30’31 Extrapolat­
ing the Dutch rates to the United States suggests 
that approximately 62,000 Americans (2.7 percent 
o f  the 2.3 million who die in the United States each 
year) might choose physician-assisted suicide if it 
were legalized and carried out with the explicit, cur­
rent consent o f  the patients. Patients with cancer are 
also likely to be the primary users o f physician-assist­
ed suicide in the United States.25’26
P R O P O R T IO N  O F  L IF E  S H O R T E N E D  BY 
P H Y S IC IA N -A S S IS T E D  S U IC ID E
Although predicting the exact date on which an 
individual patient will die is impossible, physicians 
are fairly accurate in predicting the time o f death on 
a population basis, especially for patients who die o f 
cancer.16’32 Dutch physicians estimate that 17 percent 
o f  patients receiving euthanasia or a physician’s as­
sistance with suicide at the patients’ explicit request 
had their lives shortened by less than one day, 42 
percent by one day to one week, 32 percent by more 
than one week to four weeks, and 9 percent by more 
than one m onth .30’31 Thus, more than 90 percent 
o f  Dutch patients who died as a result o f physician- 
assisted suicide or euthanasia at their own explicit re­
quest had their lives shortened by 4 weeks or less, 
with an average life reduction o f less than 3.3 weeks.
T H E  C O S T S  O F  M E D IC A L  C A R E  
F O R  D Y IN G  P A T IE N T S
Determining the costs o f  medical care at the end 
o f life and how much would be saved by legalizing
physician-assisted suicide is made difficult by several 
problems with the available data. It is speculative to 
assume that patients who might commit physician- 
assisted suicide would consume resources at a rate 
similar to that o f  patients who do not; such patients 
may be considerably different from average dece­
dents in terms o f health status, psychology, and so­
ciodemographic characteristics, using more (or few­
er) health care resources at the end o f life.25 Also, 
the best data available in the United States on the 
cost o f  medical care at the end o f life come from 
Medicare, which provides mainly acute care for the 
elderly and disabled.33’34 Studies have come to vari­
ous conclusions about whether these Medicare data 
can be extrapolated to decedents under 65 years 
old .35'38 According to recent Medicare data, for a 
beneficiary who dies o f cancer after receiving con­
ventional care, $30,397 (in 1995 dollars) is spent on 
medical care in the last year o f  life.39’40 Fully 33 per­
cent o f  the last year’s costs ($10,118 in 1995 dollars) 
are spent in the last month o f life, and 48 percent 
($14,507 in 1995 dollars) in the last two months o f 
life. (The available data do not define costs in any 
smaller increments o f time.)
E S T IM A T E D  C O S T  S A V IN G S  
F R O M  L E G A L IZ IN G  P H Y S IC IA N -A S S IS T E D  
S U IC ID E
Assuming that (1) 2.7 percent o f  patients who die 
each year (62,000 Americans) would choose physi­
cian-assisted suicide, (2 ) these patients would forgo 
an average o f four weeks o f life, and (3) the medical 
costs in the last month o f life for each patient who 
dies are $10,118 (in 1995 dollars), we estimate that 
legalizing physician-assisted suicide and euthanasia 
would save approximately $627 million in 1995 dol­
lars (Table 1). This amount is less than 0.07 percent 
o f total U.S. health care expenditures.
O V E R E S T IM A T IO N  A N D
U N D E R E S T IM A T IO N  O F  C O S T  S A V IN G S
This calculation may produce a considerable over­
estimate o f savings. In six ways, the calculation is bi­
ased to inflate the savings. First, we assumed that 
U.S. physicians would fulfill their patients’ requests 
at the same rate that Dutch physicians do. Yet in the 
Netherlands 53 percent o f  physicians have provided 
assistance with suicide or administered euthanasia, 
and just 4 percent state that they would neither 
do so nor refer a patient to another physician who 
would.29’31 In contrast, surveys o f American physicians 
suggest that a substantial majority would refuse to 
provide assistance with suicide, even if it were legal­
ized.25’26’41’42 Unless legalization greatly altered physi­
cians’ practices, having fewer American physicians 
willing to assist in suicide would probably mean that 
fewer American patients would receive such assistance.
Second, we estimated the average amount o f life
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T a b l e  1 , E s t im a t e d  C o s t  Sa v in g s  f r o m  t h e  U se  
o f  P h y s ic ia n -A s s is t e d  S u ic i d e  by P a t ie n t s  w i t h  C a n c e r  
W h o  R e c e iv e  C o n v e n t i o n a l  C a r e  ( i n  1 9 9 5  D o l l a r s ).
Percent (no.) 
W ho W ould 
Use P hysician- 
Assisted S uicide End-of-Life Health Care Costs
average M edicare costs 
— Pari- A and Part R
TWICE THE AVERAGE
M edicare costs — 
Part A and Part B
In Last Mo 
of Life 
($10,118)
In Last 2 Mo 
of Life 
($14,507)
In Last Mo 
of Life 
($20,236)




2 .7  (6 2 ,0 0 0 ) 6 2 7  m illion'* 8 9 9  m illion 1.25 billion 1.80 billion
3 .4  (7 8 ,0 0 0 ) f 789  m illion 1.13 billion 1.58 billion 2 .2 6  billion
5.0  (115 ,000 ) 1.16 billion 1.67 billion 2 .33  billion 3 .3 4  billion
7 0  (161 ,000)$ 1 .63  billion 2 .3 4  billion 3 .26  billion 4 .6 7  billion
*This amount represents the most reasonable estimate o f cost savings.
I  This percentage is the proportion o f all cases o f euthanasia and physi­
cian-assisted suicide in the Netherlands, including the cases o f euthanasia 
in which patients did not provide current consent. The number extrapo­
lates the Dutch percentage to the U.S. population.
JThis percentage is the proportion o f all dying patients who make in­
quiries about or request euthanasia or physician-assisted suicide in the 
Netherlands. Approximately one third o f such inquiries and requests are 
answered or honored. The number extrapolates the Dutch percentage to 
the U.S. population.
forgone by patients who die as a result o f  physician- 
assisted suicide at four weeks, which may be too 
high. The average time forgone by Dutch patients 
who receive euthanasia with their consent is less than 
3.3 weeks, with 59 percent forgoing 1 week o f life 
or less. Clearly, the more life forgone, the greater the 
projected savings. In addition, Dutch physicians es­
timated that 8 percent o f the patients who died as a 
result o f physician-assisted suicide or euthanasia 
would have lived longer than six months29’30; such 
patients are not “terminally ill,” as defined by Ore­
gon’s law governing physician-assisted suicide and 
most American proposals for legalization, and thus 
would not be permitted to receive a physician’s as­
sistance with suicide in the United States.
Third, we calculated the savings by using the costs 
o f care for patients with cancer and generalized these 
costs to all patients who might choose physician- 
assisted suicide. Yet because o f the intensity o f their 
care, patients with cancer have some o f the highest 
costs at the end o f life.33’34 Patients with other dis­
eases, such as multiple sclerosis or amyotrophic lat­
eral sclerosis, who might choose physician-assisted 
suicide are likely to have lower overall medical costs 
and thus are likely to represent less money saved.
Fourth, when calculating the costs at the end of 
life, we used the costs for patients receiving conven­
tional care for their cancers. The medical expendi­
tures for patients who receive hospice care during
the last two months o f life are substantially lower 
than those for patients receiving conventional care 
($9,548 vs. $14,507 in 1995 dollars), suggesting 
that the savings from physician-assisted suicide would 
be less for patients receiving hospice care.31’40'42
Fifth, recent surveys indicate that some terminally 
ill patients in the United States have died as a result 
o f physician-assisted suicide or euthanasia, although it 
is impossible to determine precisely how many.25’26’43 
The cost savings realized from these cases in which 
death was hastened are already accounted for in the 
health care system and are double-counted in our 
calculation.
Finally, we have not included the additional costs 
that legalizing physician-assisted suicide would en­
tail. Proposals for legalization include the require­
ment that a second physician confirm that the patient 
is terminally ill and understands the implications of 
requesting a physician’s assistance with suicide. Some 
proposals would mandate a psychiatric evaluation of 
patients making such a request. Others, such as O r­
egon’s Death with Dignity Act (Measure 16), re­
quire referral o f patients for counseling if they might 
have depression or another psychiatric disorder. Meas­
ure 16 also requires the state to assemble statistics on 
the use o f physician-assisted suicide. There is likely 
to be litigation, such as investigations and prosecu­
tions o f physicians who violate the safeguards. All 
these activities would increase the medical and legal 
costs, thereby reducing the net savings from physi­
cian-assisted suicide.
Conversely, several considerations suggest that 
these calculations may underestimate the potential 
savings from physician-assisted suicide. Our use of 
Medicare costs at the end o f life might have caused us 
to underestimate the total health care costs and there­
fore the potential savings. According to some, the av­
erage Medicare costs for care at the end o f life do not 
accurately reflect the costs for all dying patients, espe­
cially for patients in tertiary care facilities. Also, Medi­
care Part A and Part B do not cover all health care 
costs; indeed, substantial costs, predominantly nurs­
ing home costs, are not included.34’40 However, in the 
Netherlands, euthanasia and physician-assisted suicide 
are quite rare among patients in nursing homes — 
just 2  percent o f all cases — suggesting that the ab­
sence o f nursing home costs from these calculations 
does not produce a large underestimate.30’31
In addition, in the United States, family members 
provide substantial care for dying patients, adding to 
the overall costs o f  care at the end o f life.44 Because 
there are no studies that accurately quantify the fi­
nancial costs o f family care for dying patients, such 
costs are not usually computed in the assessments o f 
health care costs at the end o f life.40 By ending pa­
tients’ lives earlier, physician-assisted suicide would 
reduce the costs associated with family care. There 
is currently no way to quantify these savings.
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To acknowledge the uncertainty in these estimates. 
Tables 1 and 2 present analyses of the savings in var­
ious circumstances, varying the proportion of the 
population that might choose physician-assisted sui­
cide, the amount of life forgone, and the expendi­
tures for medical care at the end of life. The lower 
bound of savings assumes that 2.7 percent of dying 
Americans (62,000) might choose physician-assisted 
suicide, forgoing four weeks of life and using hospice 
care at the end of life. These assumptions produce a 
savings of $336 million (Table 2). Conversely, the 
most inflated assumptions are that 7.0 percent of dying 
Americans (161,000) might choose physician-assisted 
suicide, forgoing an average of eight weeks o f life at 
twice the average Medicare expenditures ($29,014). 
These assumptions produce savings of $4.67 billion.
M A N A G E D  C A R E  P L A N S  A N D  C O S T  
S A V IN G S  F R O M  P H Y S IC IA N -A S S IS T E D  
S U IC ID E
Although the total national savings from the legal­
ization of physician-assisted suicide might be small, 
there is concern that price competition might still 
tempt managed-care plans to encourage the practice. 
Several o f the amicus briefs submitted to the Su­
preme Court raised this specter: “It is certainly plau­
sible and perhaps even likely that budget-minded 
health care organization managers and their phvsi- 
cian-emplovees would press their dying patients to ­
ward exercising [a right to receive a physician’s assist­
ance with suicide]” and “agonized and depressed
Table 2 . Estimated Cost Savings from th e  Use 
of Physician-Assisted Suicide by Patients with Cancer 
Who Receive Hospice Care (in 1995 Dollars).
Percent {no .! 
W ho W ould 
Use Physician- 
A ssisted S uicide End-of-Life Health Care Costs
average M edicare costs 
—  Fari* A and Pari* B
In Last Mo 
of Life 
($5,413)
Wit E THE AVERAGE
M edicare costs —  Pari* A 
and Pari* B
In Last 2 Mo 
of Life 
($9,548)
In Last Mo 
of Life 
($10,826)




2.7 (62,000) 336 million 592 million 671 million 1.18 billion
3.4 (78,000)* 422 million 745 million 844 million 1.49 billion
5.0 (115,000) 622 million 1.10 billion 1.24 billion 2.20 billion
7.0 (161,000)t 871 million 1.54 billion 1.76 billion 3.07 billion
*This percentage is the proportion of all cases o f euthanasia and physi­
cian-assisted suicide in the Netherlands, including the cases of euthanasia 
in which patients did not provide current consent. The number extrapo­
lates the Dutch percentage to the U.S. population.
fThis percentage is the proportion of all dying patients who make in­
quiries about or request euthanasia or physician-assisted suicide in the 
Netherlands. Approximately one third of such inquiries and requests are 
answered or honored. The number extrapolates the Dutch percentage to 
the U.S. population.
patients would elect to have their deaths facilitated 
since their relievable suffering went unalleviated be­
cause o f their health providers’ financial impera­
tives.” 23’24 In the abstract this claim seems implausi­
ble, since one of the principal ways managed-care 
plans save money is by enrolling healthier members, 
including healthier Medicare beneficiaries, who are 
less likely to be terminally ill. Nevertheless, it may 
correspond to the motives o f some managed-care 
executives and certainly seems to express public sus­
picions. How much would managed-care plans save 
by encouraging the use of physician-assisted suicide?
One large managed-care plan currently enrolls ap­
proximately 1.7 million adults and has an annual 
budget o f almost $4.5 billion. In 1995, approxi­
mately 13,000 o f the enrolled adults died, including 
3800 who died o f cancer. Over the last six months 
o f life, the mean cost for patients enrolled in this 
managed-care plan who died o f breast cancer was 
$21,329 (in 1995 dollars), with about $9,500 spent 
in the last month o f life.45 Assuming that 2.7 percent 
o f the patients who died would have chosen phvsi- 
cian-assisted suicide (351 patients), forgoing an av­
erage o f four weeks o f life at an average savings of 
$9,500, the managed-care plan’s expenditures would 
have been reduced by $3.3 million, or less than 0.08 
percent o f its total budget. For other managed-care 
plans that tend to have higher proportions o f young, 
healthy patients with lower death rates, the absolute 
and relative savings are likely to be even smaller.
F A M IL IE S  A N D  C O S T  S A V IN G S  F R O M  
P H Y S IC IA N -A S S IS T E D  S U IC ID E
Although the cost savings to the United States 
and most managed-care plans are likely to be small, 
it is important to recognize that the savings to spe­
cific terminally ill patients and their families could be 
substantial. For many patients and their families, es­
pecially but not exclusively those without health in­
surance, the costs o f terminal care may result in large 
out-of-pocket expenses.44 Nevertheless, as compared 
with the average American, the terminally ill are less 
likely to be uninsured, since more than two thirds of 
decedents are Medicare beneficiaries over 65 years of 
age. The poorest dying patients are likely to be M ed­
icaid beneficiaries. Extrapolating from the Medicare 
data, one can calculate that a typical uninsured pa­
tient, by dying one month earlier by means of phv- 
sician-assisted suicide, might save his or her family 
$ 10 ,0 0 0  in health care costs, having already spent as 
much as $20,000 in that year. Some patients using 
intensive medical services may incur considerably 
higher health care costs. If  uninsured nonhospice pa­
tients with cancer were to choose physician-assisted 
suicide six months before their natural deaths — the 
earliest point permitted under current proposals — 
the average savings for the family could be $2 0 ,0 00 . 
Although the overall national savings from legalizing
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physician-assisted suicide might be small, for many 
families — especially those o f uninsured patients — 
the savings could be substantial. What savings level, if 
any, would motivate families to pressure patients into 
requesting a physician’s assistance with suicide is a 
matter o f speculation but one that cannot be ignored.
W H Y  A R E  T H E  C O S T  S A V IN G S  F R O M  
P H Y S IC IA N -A S S IS T E D  S U IC ID E  SO  LOW ?
The estimated cost savings from permitting phy­
sician-assisted suicide are lower than many people 
expect. One reason for this disparity is the frequent 
overestimation o f how much is spent on medical 
care at the end o f life. One commentator claimed 
that “some 70 to 90% o f our health care dollar is 
spent on the last few months o f life.”17 Others have 
suggested that the costs o f care for dying patients ac­
count for almost 30 percent o f all health care ex­
penditures.10 In fact, each year about 10 percent of 
expenditures for medical care involves patients who 
die.40 The less spent on patients who die, the smaller 
the cost savings from physician-assisted suicide.
Another reason may be that people overestimate 
the number o f Americans who die each year. Less 
than 1 percent o f Americans die each year. O f these, 
many would be unable or ineligible to request a phy­
sician’s assistance with suicide, even if it were legal­
ized: newborns with serious birth defects, minors, 
victims o f trauma, persons who die suddenly from 
myocardial infarctions or strokes, and patients with 
dementia. More important, if Americans were to 
choose physician-assisted suicide at the same rate as 
the Dutch choose euthanasia, only 0.027 percent of 
Americans might choose physician-assisted suicide if 
it were legalized. Put another way, more than 99.97 
percent o f  Americans would continue to receive the 
usual health care at the usual cost. Because phvsi- 
cian-assisted suicide would not affect the health care 
provided to the vast majority o f Americans, it would 
not substantially reduce overall health care costs.
Finally, physician-assisted suicide is not an option 
most people would be likely to choose much before 
their “natural deaths.” As the Dutch data dem on­
strate, the average amount o f life forgone by all pa­
tients electing euthanasia or physician-assisted sui­
cide is less than four weeks.30’31 Although the care 
given in the last four weeks o f life accounts for a con­
siderable proportion o f health care costs, it still rep­
resents only 33 percent o f all medical expenditures 
during the last year o f life and an even smaller frac­
tion o f lifetime health care expenditures.39’40 Consid­
ering the small fraction o f Americans who would 
choose physician-assisted suicide, the small fraction 
o f life they would forgo, and the small fraction of 
total health care expenditures associated with their 
care, the savings that would result from the legaliza­
tion o f physician-assisted suicide represent a very 
small fraction o f total health care expenditures.
C O N C L U S IO N S
Drawing on data from the Netherlands on the use 
o f euthanasia and physician-assisted suicide and on 
available U.S. data on costs at the end o f life, this 
analysis explores the degree to which the legalization 
o f physician-assisted suicide might reduce health care 
costs. The most reasonable estimate is a savings of 
$627 million, less than 0.07 percent o f total health 
care expenditures. What is true on a national scale is 
also likely to be reflected in the potential savings for 
individual managed-care plans. Physician-assisted sui­
cide is not likely to save substantial amounts o f m on­
ey in absolute or relative terms, either for particular 
institutions or for the nation as a whole.
We are indebted to Dr. Paul van der Maas, Dr. Miles Brown, Dr. 
Jane Weeks, David Guberman, Dr. Jay Jacobson, Dr. Jeff Botkin, Dr. 
David Green, Dr. Leslie Francis, Evelyn Kasworm, and Jan Van- 
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